Rating History for Taysha Gene Therapies (TSHA) by Goldman Sachs

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/4/2021 Salveen Richter Maintain Buy
(Buy)
36.00
(34.00)
 
 
  Details